bexarotene

FDA Drug Profile — Targretin, bexarotene

Drug Details

Generic Name
bexarotene
Brand Names
Targretin, bexarotene
Application Number
NDA021056
Sponsor
Bausch Health US, LLC
NDC Codes
5
Dosage Forms
GEL, CAPSULE, LIQUID FILLED
Routes
TOPICAL, ORAL
Active Ingredients
BEXAROTENE

Indications and Usage

1 INDICATIONS AND USAGE Bexarotene capsules are indicated for the treatment of cutaneous manifestations of cutaneous T-cell lymphoma in patients who are refractory to at least one prior systemic therapy. Bexarotene capsules are a retinoid indicated for the treatment of cutaneous manifestations of cutaneous T-cell lymphoma in patients who are refractory to at least one prior systemic therapy. ( 1 )